April 6th 2024
From a groundbreaking FDA approval to the hidden toll of COVID-19, here are highlights from the week in Psychiatric Times.
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
View More
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
View More
Southern California Psychiatry Conference
September 13-14, 2024
Register Now!
Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder
View More
5th Annual International Congress on the Future of Neurology®
View More
2023 Annual Psychiatric Times™ World CME Conference
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Differentiating Comorbid Bipolar Disorder and OCD
This review highlights an important diagnostic and therapeutic task: the importance of differentiating true bipolar disorder/obsessive-compulsive disorder comorbidity from BD with secondary OCD.
Read More
Novel Approaches to Bipolar: What Worked, and What Did Not, in 2019
January 30th 2020The first part of this series covered updates on traditional psychotropics-lithium, anticonvulsants, antipsychotics, and more. Here, Part 2 examines anti-inflammatories, natural supplements, and mitochondrial therapies.
Read More
The Rise and Fall of Pragmatism in Psychiatry
December 28th 2019"Psychiatry has been frozen in time since the 80s, and hence the absence of progress since then is no surprise." So says, S. Nassir Ghaemi, MD, MPH, in the next installment of Conversations in Critical Psychiatry with Awais Aftab, MD.
Read More
Psychiatry Update: Parental History, Pediatric Bipolar Disorder, and More
September 30th 2019Parental history shapes pediatric bipolar in offspring, no evidence for deterioration in neurocognitive functioning, clinical course predictors identified-these are some of the latest findings in bipolar disorder research.
Read More
Mixed Features, Suicide, and Adolescents at Risk
September 26th 2019Assessment of suicidal risk in adolescents is a solemn professional obligation that involves obtaining as much information as possible from family members or caregivers. Evaluation of mood disorders is an essential part of the assessment.
Read More